Hepatitis C: Difference between revisions

From Guide to YKHC Medical Practices

Line 5: Line 5:
===Resources/References===
===Resources/References===
*[http://dhss.alaska.gov/dhcs/Documents/pharmacy/forms/AK_Hep_C_DAA_Fax_Form_20171001.pdf Alaska Medicaid Prior Authorization Form Hepatitis C Direct Acting Antivirals – New Starts]
*[http://dhss.alaska.gov/dhcs/Documents/pharmacy/forms/AK_Hep_C_DAA_Fax_Form_20171001.pdf Alaska Medicaid Prior Authorization Form Hepatitis C Direct Acting Antivirals – New Starts]
* [[media:Liver Disease Updates 10.6.17.pdf|Liver Disease Updates 2017(PowerPoint Presentation)
* [[media:Liver Disease Updates 10.6.17.pdf|Liver Disease Updates 2017]] (PowerPoint Presentation)
* [[media:Hep C Update 2015.pdf|Hepatitis C Update 2015]] (PowerPoint Presentation)
* [[media:Hep C Update 2015.pdf|Hepatitis C Update 2015]] (PowerPoint Presentation)

Revision as of 00:01, 22 October 2020

Anyone with untreated Hepatitis C can be given Mayret for 8 weeks. Please call the ANMC Hepatology team with any questions and see the Resources below for a link to the Prior Authorization Form.

If a patient is to be started on Mavyret, the medication prior authorization form needs to be filled out by BOTH patient and provider prior to the medication being dispensed. It is ideal to have this form completed during the visit and given to your clinic pharmacist when sending the Rx to the pharmacy.

Resources/References